Pep Therapy
3 known investors
PEP-Therapy is a biotechnology company developing peptide-based cancer therapeutics, with a lead product PEP-010 targeting cancers such as pancreatic and ovarian cancer. Its drug candidate induces apoptosis in cancer cells and has received FDA Orphan Drug Designation for pancreatic cancer.
Investors · 3
Frequently asked questions
- What does Pep Therapy do?
- PEP-Therapy is a biotechnology company developing peptide-based cancer therapeutics, with a lead product PEP-010 targeting cancers such as pancreatic and ovarian cancer. Its drug candidate induces apoptosis in cancer cells and has received FDA Orphan Drug Designation for pancreatic cancer.
- Who are Pep Therapy's investors?
- Pep Therapy's investors include Biotech Investments S.R.O, Italian Angels for Growth, CAP HORN VC.